Ethylamine → 3-(1-{[3-(dimethylamino)propyl]sulfonyl}-4-piperidinyl)-5-{3-[(ethylamino) methyl]phenyl}-1H-indole-7-carboxamide
反応式
[CH3:1][N:2]([CH3:35])[CH2:3][CH2:4][CH2:5][S:6]([N:9]1[CH2:14][CH2:13][CH:12]([C:15]2[C:23]3[C:18](=[C:19]([C:32]([NH2:34])=[O:33])[CH:20]=[C:21]([C:24]4[CH:29]=[CH:28][CH:27]=[C:26]([CH:30]=O)[CH:25]=4)[CH:22]=3)[NH:17][CH:16]=2)[CH2:11][CH2:10]1)(=[O:8])=[O:7].[CH2:36]([NH2:38])[CH3:37].C1COCC1.[BH4-].[Na+]>CO.C(Cl)Cl>[CH3:35][N:2]([CH3:1])[CH2:3][CH2:4][CH2:5][S:6]([N:9]1[CH2:10][CH2:11][CH:12]([C:15]2[C:23]3[C:18](=[C:19]([C:32]([NH2:34])=[O:33])[CH:20]=[C:21]([C:24]4[CH:29]=[CH:28][CH:27]=[C:26]([CH2:30][NH:38][CH2:36][CH3:37])[CH:25]=4)[CH:22]=3)[NH:17][CH:16]=2)[CH2:13][CH2:14]1)(=[O:8])=[O:7]参加物
6
反応物 4
生成物 1
試薬・触媒・溶媒 1
実験手順
To a solution of 3-(1-{[3-(dimethylamino)propyl]sulfonyl}-4-piperidinyl)-5-(3-formylphenyl)-1H-indole-7-carboxamide (25 mg, 0.05 mmol) in MeOH/CH2Cl2 (1 mL/1 mL) was added 2M ethyl amine in THF (0.15 mL, 0.30 mmol). The reaction mixture was stirred at room temperature for 2 hours before NaBH4 (12 mg, 0.3 mmol) was added. The reaction mixture was stirred at room temperature overnight and evaporated all the solvent. The residue was purified by using a Gilson semi-preparative HPLC system, eluting with 10% B to 80% B, where A=H2O (0.1% trifluoroacetic acid) and B=CH3CN (0.1% trifluoroacetic acid) pumped at 25 mL/min to give the title compound (11 mg, 52%)
後処理
- additionwas added
- customevaporated all the solvent
- customThe residue was purified
- washeluting with 10% B to 80% B, where A=H2O (0.1% trifluoroacetic acid) and B=CH3CN (0.1% trifluoroacetic acid)
出典と根拠
- ORDレコード
- ord-29c20d64a8d94fc9bd1af1c9bc018a14
- 出典データセット
- uspto-grants-2010_12
- 特許番号
- US07858796B2
反応ノート
読み込み中…